Clinical and biophysics evaluation of the cutaneous modifications following the local use of a lotion containing 0,1 % of trétinoïne.

Pierre Fabre Dermo-cosmétique0 sites24 target enrollmentSeptember 28, 2015

Overview

No summary available.

Registry

who.int

Start Date

September 28, 2015

End Date

February 20, 2014

Last Updated

4 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

Male

Sponsor

Pierre Fabre Dermo-cosmétique

•Relative to the population:
•O male Adult.
•O Age included between 18 and 30 inclusive years.
•O Phototype I to IV
•o Pilosity reduced at the level of the top of the back
•o Subject affiliated to a French national insurance scheme,
•o Subject having given its written consent to its participation in the study.
•O Registration in the national file of the persons who lend themselves to biomedical researches.
•Relative to the pathology:
•Subject having a moderated acne at the level of the back, the evaluation by the investigator global assessment of the acne (rank 1, 2, 3\)

•Relative to the pathologies:
•· Any dermatological pathology on the back, other than the acne.
•· Existence of a chronic affection or an evolutionary acute pathology which can interfere with the study.
•Relative to treatments:
•· Use of a self\-tanning, keratolytic or exfoliating product on the back in 2 weeks preceding the inclusion.
•· Use on the back of any product which can interfere with the study (produced moisturizer, care product) in 2 weeks preceding the inclusion.
•· Treatment by oral route by antibiotics in 2 weeks preceding the inclusion.
•· Treatment by oral route by anti\-inflammatory or corticoid during more than 2 consecutive days in 2 weeks preceding the inclusion.
•\- Treatment by local use on the study zone : by anti\-inflammatory, corticoid or antibiotics during more than 2 consecutive days in 2 weeks preceding the inclusion.
•· Hormonal treatment (in thyroid, anti\-acned) by oral route in two months preceding the inclusion.